|View printer-friendly version|
|December 14, 2004 5:24 p.m.|
|Teva Announces Tentative Approval Of Metformin Hcl Extended Release Tablets, 750 Mg|
Jerusalem, Israel, December 14, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Metformin Hydrochloride Extended Release Tablets, 750 mg. Final approval is anticipated upon the expiration of any relevant exclusivity period.